(Q37003482)

17 August 2017

1 reference

title

The Lewy body in Parkinson's disease: molecules implicated in the formation and degradation of alpha-synuclein aggregates (English)

1 reference

17 August 2017

1 reference

1 reference

Koichi Wakabayashi

1

1 reference

17 August 2017

Kunikazu Tanji

series ordinal

2

1 reference

17 August 2017

Fumiaki Mori

series ordinal

3

1 reference

17 August 2017

Hitoshi Takahashi

series ordinal

4

1 reference

17 August 2017

1 October 2007

1 reference

17 August 2017

1 reference

17 August 2017

27

1 reference

17 August 2017

494-506

1 reference

17 August 2017

5

1 reference

Protein aggregation and neurodegenerative disease

17 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

alpha-Synuclein locus triplication causes Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Alpha-synuclein in Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

NACP/alpha-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Neurodegeneration and neuroprotection in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Lewy-body formation is an aggresome-related process: a hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Lewy bodies in Parkinson's disease: protectors or perpetrators?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Lewy bodies in cerebral cortex, report of three cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

The distribution of Lewy bodies in the central and autonomic nervous systems in idiopathic paralysis agitans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Parkinson's disease: Distribution of Lewy bodies and monoamine neuron system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Lewy bodies in the lower sacral parasympathetic neurons of a patient with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

The intermediolateral nucleus and Clarke's column in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Amygdala pathology in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Cortical Lewy body-containing neurons are pyramidal cells: laser confocal imaging of double-immunolabeled sections with anti-ubiquitin and SMI32.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Parkinson's disease with involvement of the parasympathetic ganglia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Neuropathology of autonomic nervous system in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Staging of brain pathology related to sporadic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Accumulation of phosphorylated alpha-synuclein in aging human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Colloid (hyaline) inclusion bodies in the central nervous system: their presence in the substantia nigra is diagnostic of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Relationships between Lewy bodies and pale bodies in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Accumulation of alpha-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Morphogenesis of Lewy bodies: dissimilar incorporation of alpha-synuclein, ubiquitin, and p62.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Relationship among alpha-synuclein accumulation, dopamine synthesis, and neurodegeneration in Parkinson disease substantia nigra.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Crosslinking of alpha-synuclein by advanced glycation endproducts--an early pathophysiological step in Lewy body formation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Agrin binds alpha-synuclein and modulates alpha-synuclein fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Dementia with beta-amyloid deposition: involvement of alpha B-crystallin supports two main diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

alpha B crystallin expression in non-lenticular tissues and selective presence in ubiquitinated inclusion bodies in human disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Lewy bodies contain beta-amyloid precursor proteins of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Pathological lesions of Alzheimer's disease and dementia with Lewy bodies brains exhibit immunoreactivity to an ATPase that is a regulatory subunit of the 26S proteasome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Basic fibroblast growth factor binds to filamentous inclusions of neurodegenerative diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Phosphorylated IkappaBalpha is a component of Lewy body of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

The co-chaperone carboxyl terminus of Hsp70-interacting protein (CHIP) mediates alpha-synuclein degradation decisions between proteasomal and lysosomal pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Ca2+/calmodulin-dependent protein kinase II immunoreactivity in Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Relative sparing in Parkinson's disease of substantia nigra dopamine neurons containing calbindin-D28K.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Synaptophysin and chromogranin A immunoreactivities of Lewy bodies in Parkinson's disease brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Glial involvement in the degeneration process of Lewy body-bearing neurons and the degradation process of Lewy bodies in brains of dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Complement activation in the Parkinson's disease substantia nigra: an immunocytochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Cell cycle aberrations by alpha-synuclein over-expression and cyclin B immunoreactivity in Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Role of cytochrome c as a stimulator of alpha-synuclein aggregation in Lewy body disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Quantitative proteomic analysis of mitochondrial proteins: relevance to Lewy body formation and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Dorfin localizes to the ubiquitylated inclusions in Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, and amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Dorfin Localizes to Lewy Bodies and Ubiquitylates Synphilin-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

14-3-3 proteins in Lewy bodies in Parkinson disease and diffuse Lewy body disease brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

14-3-3 protein is a component of Lewy bodies in Parkinson's disease-mutation analysis and association studies of 14-3-3 eta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

The role of G-protein-coupled receptor kinase 5 in pathogenesis of sporadic Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Interaction of TPPP/p25 protein with glyceraldehyde-3-phosphate dehydrogenase and their co-localization in Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

TorsinA and heat shock proteins act as molecular chaperones: suppression of alpha-synuclein aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Neural heme oxygenase-1 expression in idiopathic Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

A possible role for humoral immunity in the pathogenesis of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Kinase activity is required for the toxic effects of mutant LRRK2/dardarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

LRRK2 expression in normal and pathologic human brain and in human cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

LRRK2 protein is a component of lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

LRRK2 in Parkinson's disease and dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Sphingomyelin in Lewy inclusion bodies in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Microtubule-associated protein 1B is a component of cortical Lewy bodies and binds alpha-synuclein filaments

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Immunocytochemical localization of synaptic vesicle-specific protein in lewy body-containing neurons in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Abnormal patterns of microtubule-associated protein-2 (MAP-2) immunolabeling in neuronal nuclei and Lewy bodies in Parkinson's disease substantia nigra brain tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Multicatalytic proteinase is present in Lewy bodies and neurofibrillary tangles in diffuse Lewy body disease brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Multicatalytic proteinase is associated with characteristic oval structures in cortical Lewy bodies: an immunocytochemical study with light and electron microscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Immunohistochemistry using antibodies to alpha-interferon and its induced protein, MxA, in Alzheimer's and Parkinson's disease brain tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

NEDD8 protein is involved in ubiquitinated inclusion bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Lewy Bodies of Parkinson's Disease Contain Neurofilament Antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Epitopes located in spatially separate domains of each neurofilament subunit are present in parkinson's disease lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

NUB1 suppresses the formation of Lewy body-like inclusions by proteasomal degradation of synphilin-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Pael-R is accumulated in Lewy bodies of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

p35nck5a and cyclin-dependent kinase 5 colocalize in Lewy bodies of brains with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

PINK1 protein in normal human brain and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Prolyl-isomerase Pin1 accumulates in lewy bodies of parkinson disease and facilitates formation of alpha-synuclein inclusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Proteasomal inhibition by alpha-synuclein filaments and oligomers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Expression patterns of retinoblastoma protein in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Association of the cytoskeletal GTP-binding protein Sept4/H5 with cytoplasmic inclusions found in Parkinson's disease and other synucleinopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Ubiquitylation of synphilin-1 and alpha-synuclein by SIAH and its presence in cellular inclusions and Lewy bodies imply a role in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Immunocytochemical localization of synphilin-1, an alpha-synuclein-associated protein, in neurodegenerative disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Synphilin-1 and parkin show overlapping expression patterns in human brain and form aggresomes in response to proteasomal inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

The autosomal recessive juvenile Parkinson disease gene product, parkin, interacts with and ubiquitinates synaptotagmin XI

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

The presence of tau distinguishes Lewy bodies of diffuse Lewy body disease from those of idiopathic Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Colocalization of Tau and Alpha-Synuclein Epitopes in Lewy Bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Tissue transglutaminase-induced aggregation of alpha-synuclein: Implications for Lewy body formation in Parkinson's disease and dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

A close association of torsinA and alpha-synuclein in Lewy bodies: a fluorescence resonance energy transfer study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Tropomyosin distinguishes Lewy bodies of Parkinson disease from other neurofibrillary pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Natively unfolded tubulin polymerization promoting protein TPPP/p25 is a common marker of alpha-synucleinopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

p25alpha Stimulates alpha-synuclein aggregation and is co-localized with aggregated alpha-synuclein in alpha-synucleinopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Tyrosine hydroxylase protein in Lewy bodies of parkinsonian and senile brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man, including those of Parkinson's disease, Pick's disease, and Alzheimer's disease, as well as Rosenthal fibres in cerebellar astrocytomas, cytoplasmic bodie

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Lewy bodies are ubiquitinated. A light and electron microscopic immunocytochemical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Ubiquitin carboxyl-terminal hydrolase (PGP 9.5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Positive immunoreactivity for vesicular monoamine transporter 2 in Lewy bodies and Lewy neurites in substantia nigra

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Phosphorylated alpha-synuclein is ubiquitinated in alpha-synucleinopathy lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Alpha-synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Ubiquitination of alpha-synuclein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Initiation and Synergistic Fibrillization of Tau and Alpha-Synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Interface between tauopathies and synucleinopathies: A tale of two proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Parkin-mediated lysine 63-linked polyubiquitination: a link to protein inclusions formation in Parkinson's and other conformational diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Ubiquitin-proteasome system and Parkinson's diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Biochemical and pathological characterization of Lrrk2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

An early cytoplasmic change before Lewy body maturation: an ultrastructural study of the substantia nigra from an autopsy case of juvenile parkinsonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

The cellular pathology of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Annular alpha-synuclein protofibrils are produced when spherical protofibrils are incubated in solution or bound to brain-derived membranes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Neurodegenerative disease: amyloid pores from pathogenic mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

Alpha-synuclein structure, posttranslational modification and alternative splicing as aggregation enhancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2007.00803.X

10.1111/J.1440-1789.2007.00803.X

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference